Apoptosis induction and migration suppression through regulation of IGF-1R/FoxO signaling pathways in Panc1 pancreatic cancer cells by hAMSCs secretome: An in vitro cell-based therapy
Authors:
Open Access
- 10 March 2026
- journal article
- Published by Elsevier in Cancer Treatment and Research Communications
- Vol. 47, 101172
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Exploring the dichotomy of the mesenchymal stem cell secretome: Implications for tumor modulation via cell-signaling pathwaysInternational Immunopharmacology, 2024
- Therapeutic effects of hAMSCs secretome on proliferation of MDA-MB-231 breast cancer cells by the cell cycle arrest in G1/S phaseClinical and Translational Oncology, 2023
- The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/Stat3 signalingMedical Oncology, 2022
- The Use of Normal Stem Cells and Cancer Stem Cells for Potential Anti-Cancer Therapeutic StrategyTissue Engineering and Regenerative Medicine, 2018
- Re-evaluating the role of FOXOs in cancerSeminars in Cancer Biology, 2018
- Regulation of FOXO Factors in Mammalian Cells2018
- Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cellsBiomedicine & Pharmacotherapy, 2016
- Prognostic and therapeutic relevance of the IGF pathway in Ewing’s sarcoma patientsTargeted Oncology, 2013
- FoxOs Are Lineage-Restricted Redundant Tumor Suppressors and Regulate Endothelial Cell HomeostasisCell, 2007
- Mechanism of activation of protein kinase B by insulin and IGF‐1.The EMBO Journal, 1996